News

US FDA approves UroGen's bladder cancer drug
The U.S. Food and Drug Administration on Thursday approved UroGen Pharma's drug to treat a type of bladder cancer, providing ...
FDA wants to use AI to speed up drug approval process
The Food and Drug Administration (FDA) is looking to AI to solve the problem of lengthy approval processes, as the Trump ...
McKnight's Senior Living9h
FDA plans to use AI to speed up drug and food safety reviews
But there are limits. Some FDA staff said Elsa often gave wrong answers and has to be double-checked. Others said the tool ...
FDA Will Use AI to Approve Drugs and Devices Faster
Learn more about the generative AI technology that will be used at the Food and Drug Administration (FDA) to speed up reviews ...
FDA approves polypill Widaplik for hypertension
The U.S. Food and Drug Administration has approved George Medicines' Widaplik (telmisartan, amlodipine, and indapamide) for ...
After Slashing Thousands of Jobs, Trump’s FDA Wants to Use AI to Rapidly Approve New Drugs
AI is slowly permeating all corners of the federal government, including the Food and Drug Administration, where, according ...
Fierce Biotech1d
FDA aims for 'rapid or instant' drug reviews, with AI tool initially assessing applications
The Food and Drug Administration has gone all in on AI since Martin Makary, M.D., took over the agency, most recently ...
Soy Carmín1d
Food and Drug Administration FDA
Find out about the latest happenings in the world of entertainment, and also learn from experts about: relationships, ...
WTVR.com3h
FDA Approves Merck’s Enflonsia to prevent RSV in infants
The Food and Drug Administration has approved a new drug from Merck designed to protect infants from respiratory syncytial ...
FDA to use AI in drug approvals to ‘radically increase efficiency’
With a Trump-driven reduction of nearly 2,000 employees, agency officials view artificial intelligence as a way to speed ...
UroGen Pharma Shares Rise on FDA Approval of Bladder Cancer Drug
UroGen Pharma shares surged after the company received Food and Drug Administration approval for bladder cancer drug Zusduri, previously known as UGN-102. The stock was recently up 36% to $9.96. Prior ...